GNH USA

Europe — EMA

Nalador (Sulprostone)

GNH USA supplies Nalador (Sulprostone), a prostaglandin E2 analog for induction of labor and gastric ulcer treatment. Request a quote for global supply.

Sulprostone

Request sourcing

1
Pack/s

What is Sulprostone?

Sulprostone, the active ingredient in Nalador, is a prostaglandin E2 analog presented as an intravenous solution for intravenous use. It acts as a uterotonic and gastroprotective agent, employed to induce labor, treat gastric ulcer disease, and prevent gastric lesions associated with NSAID therapy.

GNH USA supplies Nalador as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution aligned to EU regulatory standards. The company provides quality‑assured products to healthcare institutions across multiple continents, ensuring reliable supply chains and compliance with Good Distribution Practice.

What is Sulprostone used for?

Sulprostone is a prostaglandin E2 analog used in obstetric and gastroenterology settings to modulate uterine activity and enhance gastric mucosal defense.

- Induction of labor: facilitates uterine contractions to initiate childbirth. - Gastric ulcer treatment: promotes gastric mucosal protection and healing of ulcer lesions. - Prevention of NSAID‑induced gastric lesions: reduces risk of gastric injury in patients receiving non‑steroidal anti‑inflammatory drugs.

What are the side effects of Sulprostone?

Sulprostone may be associated with a range of adverse reactions, which are classified by frequency and severity.

Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Vomiting: occasional episodes. - Diarrhea: loose stools. - Uterine hyperstimulation: excessive uterine contractions. - Flushing: transient skin redness.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure. - Pulmonary edema: fluid accumulation in the lungs. - Allergic reactions: anaphylaxis, rash, or angioedema.

What precautions apply to Sulprostone?

When using Sulprostone, clinicians should observe specific precautions to minimize risks and ensure safe administration.

- Patient assessment: evaluate cardiovascular status and uterine activity before infusion. - Contraindications: avoid in patients with known hypersensitivity to prostaglandins or severe cardiac disease. - Monitoring: continuously monitor blood pressure, heart rate, and uterine contraction pattern during treatment. - Drug interactions: review concomitant medications that may affect prostaglandin pathways or hemodynamics. - Use in pregnancy: limit to obstetric indications under specialist supervision, considering fetal monitoring. - Store at ambient temperature: keep below 25°C, protect from light and moisture, and retain in original container.

What does Sulprostone interact with?

Sulprostone can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - NSAIDs: may reduce gastroprotective effect and increase risk of gastric injury. - Antihypertensives: additive hypotensive effect, leading to significant blood pressure drop. - Oxytocin: combined uterotonic action may cause uterine hyperstimulation.

Moderate Interactions (Monitor Closely): - Anticoagulants: increased bleeding risk due to mucosal irritation. - Diuretics: may enhance hypotensive response. - Beta‑blockers: may blunt compensatory heart rate increase during hypotension.

Frequently asked questions

What is Nalador used for?+
Nalador contains sulprostone, which is employed as a uterotonic to induce labor and as a gastroprotective agent to treat gastric ulcers and to prevent gastric lesions that can occur with non‑steroidal anti‑inflammatory drug therapy.
How does sulprostone work?+
Sulprostone binds to prostaglandin E2 (EP) receptors, stimulating uterine smooth‑muscle contraction and enhancing gastric mucosal defenses by increasing mucus and bicarbonate secretion, improving blood flow, and reducing gastric acid output.
What is the usual dose of Nalador?+
The dosing regimen for Nalador is determined by the prescribing clinician based on the specific indication, patient condition, and local guidelines. Exact dose and infusion rate should be individualized and documented by the healthcare professional.
Is sulprostone safe in pregnancy or breastfeeding?+
Sulprostone is used during pregnancy for labor induction under specialist supervision, but its safety profile requires careful fetal monitoring. Limited data are available for breastfeeding; the decision to continue treatment should be made by the prescriber after weighing potential benefits and risks.
How do I order Nalador from GNH USA?+
To request Nalador, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.
How does Nalador compare with the main alternative drug or class?+
The primary alternative to sulprostone is dinoprostone, another prostaglandin E2 analog. Both agents induce uterine contractions, but sulprostone has a shorter half‑life and may produce a more rapid onset of action, while dinoprostone is often available in oral or vaginal formulations.
What are the storage and handling requirements for Nalador?+
Nalador should be stored at ambient temperature, below 25 °C, protected from light and moisture, and kept in its original packaging. Avoid freezing the solution and ensure the container is sealed to maintain sterility until use.
How is Nalador administered?+
Nalador is supplied as an intravenous solution and is administered by slow IV infusion under continuous clinical monitoring. The infusion rate and total volume are set by the treating physician according to the therapeutic goal.
What are the most serious risks to watch for with Nalador?+
Serious adverse events include severe hypotension, uterine hyperstimulation leading to fetal distress, pulmonary edema, and rare allergic reactions such as anaphylaxis. Prompt recognition and supportive measures are essential if these events occur.
Who should not use Nalador?+
Nalador is contraindicated in patients with known hypersensitivity to sulprostone or other prostaglandins, those with severe cardiac disease, uncontrolled hypertension, or active severe bleeding. It should also be avoided in women with a history of uterine rupture or in settings where labor induction is not indicated.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Sulprostone
Route
Intravenous Use
Manufacturer
Teofarma S.R.L.
Origin
EU

Related products

Nalador

Nalador

Sulprostone

Teofarma S.R.L.
EU
Nalador

Nalador

Sulprostone

Teofarma S.R.L.
EU
Nalador

Nalador

Sulprostone

Teofarma S.R.L.
EU
Nalador

Nalador

Sulprostone

Teofarma S.R.L.
EU